Limerick East): I move:
That Dáil Éireann,
(a) notes the Report of the Tribunal of Inquiry into the Blood Transfusion Service Board (BTSB) and acknowledges the gravity of the findings made against the Blood Transfusion Service Board, its servants and agents;
(b) accepts in full the recommendations of the Report;
(c) fully understands the extraordinary anguish and distress experienced by the victims and their families;
(d) notes and acknowledges the widespread sense of public outrage at the matters disclosed in the Report;
(e) supports the Minister for Health's request to the BTSB to make known its position on liability in all outstanding cases forthwith, in the light of the findings in the Report;
(f) supports the Government's intention to reappraise and amend the Scheme of Compensation and its Terms of Reference, including the question of whether the Tribunal should be established on a statutory basis in the light of the Report, the reappraisal to take place following consultation with representatives of the victims and with the Chair of the Compensation Tribunal, and consideration of any necessary legal advice;
(g) notes the Government's decision that the benefits of any adjustment to the Compensation Scheme will be made available to all victims, including in particular cases which have already been determined by the Tribunal, or which will be determined between now and the date any adjustments are put in place, and
(h) notes that the Government will not seek to resile from or repudiate any of the findings of fact in the Tribunal Report in any proceedings either in Court or before the Compensation Tribunal.
Before I deal with the terms of the motion it is incumbent on me to make a number of points of relevance. I know I speak for everybody in this House and throughout the country, regardless of political affiliation, when I say it is almost impossible to come to terms with the enormity of the scandal surrounding the hepatitis C infection of the anti-D product and the blood supply. Notwithstanding our best efforts to do so, it will take a considerable length of time for all of us to comprehend fully the horrendous effect which this scandal has had, and continues to have, on the health and everyday lives of innocent victims and their families. I truly believe no words of mine can ever adequately apologise to the 1,600 women and men for the damage done to them by a system in which they had previously placed their fullest trust and confidence.
Trauma and fear has been engendered in many innocent people by this experience. There is some recompense in the recognition that grievous wrongs were committed. There is some recompense too in the unequivocal allocation of responsibility for these wrongs by the tribunal of inquiry. There is some minor recompense also in the monetary awards to the affected victims — awards which we can only hope alleviate the suffering and distress expressed so heartrendingly by the victims and their immediate families. Nothing, however, can ever fully or irrevocably compensate them for being infected with hepatitis C — a condition for which as yet, unfortunately, there is no cure.
The formidable task of disentangling the complex facts of this tragedy, of putting order on them and setting them out plainly, in language which precisely and exactly conveys the awfulness of these events, was entrusted by this House to Mr. Justice Finlay, and has been discharged by him with unprecedented efficiency and expedition for which I wish to record my thanks, the thanks of the Government, and of the House.
The end product of this House's decision to establish this tribunal is that there is now available for all who wish to avail of it — victims, participants, politicians, doctors, the public as a whole — a clear and coherent account of this matter, of who is responsible, and of what is now to be done. The truth has now been laid bare, a number of recurrent controversies laid to rest, and responsibility allocated in a fair, just and impartial manner.
It does not make happy reading. No citizen, whether victim, participant in the events described, or mere concerned observer, can fail to be moved and humbled by the account of the distress and fortitude of those who have suffered and continue to suffer from the events described.
The report gives us a coherent account of what has occurred and why, but it is considerably more than merely a history. It is an unemotional indictment of past procedures at the BTSB, and is unequivocal in its apportionment of blame to certain named members of staff.
It offers welcome and succinct illumination on a number of difficult legal issues, for example, the application of the Therapeutic Substances Act 1932; but it also looks to the future. From the victim's point of view it sets out the factual basis upon which claims for compensation, either in court or before the tribunal will henceforth be based, and the State will not seek to repudiate or resile from any of the tribunal's findings in any such forum. From the point of view of the blood supply it sets out a number of important recommendations, all of which are being accepted in full. The exceptional command of the facts exhibited by Mr. Justice Finlay lends to his recommendations an authority and a widespread acceptance that ensures that the implementation of his recommendations in full will provide a sound basis for restoring full confidence to the blood supply.
I cannot allow this opportunity to pass without commenting on the most recent incident involving the BTSB, namely contacting an infected victim with a view to obtaining blood. Mistakes such as these, even when there is no risk to the blood supply, are simply unacceptable. I have made my views known trenchantly to the chairman and chief executive of the BTSB and, while I accept that great strides have been made in reforming the operations of the BTSB, it must be fully recognised that this latest incident has added to the negative perception of that organisation which the current management has done so much to dispel. Notwithstanding the real difficulty people may have in coming to terms with what has happened, the truth is that we need blood, our hospitals need blood, and it is grossly irresponsible to call for the closing down of the BTSB or for the sacking of a public servant who has devoted such an enormous amount of time, effort and dedication to resolving the problems of the BTSB.
Undoubtedly, mistakes were made but I will not be satisfied until such time as we can with total confidence rule out even the most minor error, because each such error, no matter how small, can undermine confidence in the BTSB.
Huge strides have been made to improve standards at the BTSB. The work of Mr. Liam Dunbar and Professor Shaun McCann has been invaluable in reorganising the BTSB and in setting and implementing new standards and procedures which ensure that the mistakes of the past will not recur. Management has drawn heavily on the recommendations of the Bain Consultancy report in forming a strategic plan, much of which is already implemented.
The acceptance of recommendations in Mr. Justice Finlay's report will further improve standards at the BTSB. I will deal with these recommendations in some detail. I have already stated publicly that the Government accepts the recommendations of the report. These recommendations will be implemented as quickly as possible. The report makes six significant recommendations on the future workings of the Blood Transfusion Service Board and the Irish Medicines Board.
Those portions of the development plan for the BTSB for the period 1996-9 which have not yet been implemented will be implemented without delay. I will ensure that the 1999 target date for completion will be met. In particular, I have approved the relocation of Pelican House to the campus of St. James's Hospital, which will be the site for a new headquarters for the BTSB. This new building will ensure that state-of-the-art laboratories, including all the necessary equipment and staff, can be put in place to ensure that our national blood service will have the required range of facilities to carry it through to the 21st century. Likewise the renewal or replacement of the BTSB unit in Cork will be commenced immediately. The estimated capital cost for the completion of the development plan is £20 million.
The tribunal has made detailed recommendations in relation to the monitoring of the BTSB by the Irish Medicines Board. In response to the expert group report of April 1995 I have given the Irish Medicines Board statutory responsibility for the inspection of the collection, screening, processing and quality control facilities and procedures in respect of blood, blood products and plasma derivatives with a view to ensuring their safety and quality. The tribunal has recommended that the Irish Medicines Board should carry out at least two full inspections of the BTSB each year. This has already been implemented in that the arrangement now is that the IMB carries out four inspections of the BTSB each year.
My Department has commenced discussions with the Irish Medicines Board with a view to implementing a recommendation that it should be required to make an annual report to the Minister, for publication, on the outcome of these inspections and also on any reports received by the IMB of abnormal reactions to blood or blood products from any person or institution. The tribunal, in what is a very important recommendation, has recommended that there should be a statutory obligation on medical and nursing personnel to report contemporaneously all abnormal reactions to blood or blood products to the IMB and the BTSB, and that the BTSB should also be obliged to report to the IMB on all abnormal reactions of which it becomes aware. The tribunal also recommends that failure by any employee of the BTSB to report such abnormal reaction if committed intentionally or by gross negligence should be a criminal offence. I am accepting this recommendation. There are potentially difficult legal issues which will have to be teased out in the course of its implementation, and I have instructed my Department to proceed immediately with this work.
A Blood Service Consumers' Council, including representation from those who regularly receive blood and those who regularly donate blood, will be set up in the immediate future. This will make a major contribution to the maintenance of public confidence in the supply of blood and blood products. It is vital that members of the general public should have an advisory role in the BTSB.
The report of the tribunal is critical of the recall of the anti-D product undertaken by the BTSB in 1994 and has recommended that the BTSB should forthwith prepare a new standard operating procedure for a recall of any product the safety of which is suspected. I have instructed my Department to commence the process of implementing this recommendation with the BTSB.
The tribunal has also looked at the difficulty which could arise if it was again necessary to stop using a particular blood product at short notice, but there was no product authorisation in place for alternatives which could be imported quickly as an emergency replacement. The tribunal points out that a commercial undertaking may not be concerned to undergo the trouble or expense to obtain a product authorisation on the off-chance that its supplies may be needed in an emergency. The tribunal has asked that a possible solution should be considered whereby the present regulations would be amended to provide for what it terms "standby" or "emergency" product authorisations to cover such situations. This is a most worthwhile suggestion which I have instructed my Department to investigate without delay. I am accepting the tribunal's recommendation that, if such a scheme is feasible, the BTSB should be required to make use of it so that "standby" authorisations will be in place for products such as anti-D and factor VIII.
The implementation of the tribunal's recommendations will build on the work already carried out by the new management in the BTSB to ensure as far as possible the safety of blood and blood products into the future. The necessary groundwork has been put in place by the new management of the BTSB in the past two years in respect of many of these matters.
Hundreds and thousands of people in this country have over decades given freely millions of donations of their blood in order to maintain, sustain and extend life for those critically ill or critically injured. Our blood supply system is among a small handful of unique voluntary blood supply systems. I appeal to people on all sides of this House to approach the current debate on how best to protect and promote the integrity of the national blood supply with humility, with a sense of proportion and balance and with a real sense of responsibility for a public duty in its broadest meaning. In the interests of the nation as a whole, Deputies on all sides of the House, while exercising their absolute right to scrutinise Government policy at all times, will accept that the voluntary blood supply is a national asset which should not be unfairly exposed to partisan politics, whatever about particular criticisms.
As Deputies will be aware, I met with representatives of Positive Action last evening in response to a letter it sent to me on 14 March last outlining its views arising from publication of the tribunal report. Positive Action has requested a full reappraisal of the compensation tribunal. The reappraisal which the Government is embarking upon is required principally because the state of knowledge has been altered drastically by the publication of this report.
The Government has decided to place the compensation scheme on a statutory basis but has resolved that the operation of the compensation tribunal should not be disrupted or delayed while the scheme is being prepared and the statute drafted and enacted. The Government will give this work priority, but the House is well aware that even with full co-operation on all sides, legislation takes time, and I want the facility of the compensation tribunal to be in place continuing its work for the benefit of those who wish to process their claims through that tribunal. As the terms of reference in the motion state, any advantage conferred by any reappraisal of the terms of the tribunal will also apply to those who have already had their cases processed by the tribunal or those who in the interim will seek to process claims through the tribunal.
Considerable public attention has been given to the prohibition in the existing terms of reference of any award of aggravated or punitive damages. It has been pointed out that the option of awarding such damages is available to the High Court but not available to the tribunal, and that it would be preferable if the compensation tribunal had precisely the same freedom as the High Court in this regard. Accordingly, I will be proposing that this restrictive provision be removed from the terms of reference of the tribunal, and that it will be free to award damages on exactly the same basis as the High Court. It will be for the tribunal to decide whether such charges are appropriate and how they should be measured when that question arises. In considering that question, the compensation tribunal will be informed that the Government accepts the findings of the tribunal of inquiry, and that the report's findings of fact should be accepted by the compensation tribunal. I will proceed with the reappraisal of the compensation tribunal in full consultation with representatives of the victims. This is the Government's first response to this issue, but we intend to hold ongoing consultations to ensure that a satisfactory statutory scheme can be brought before the House.